---
schema_version: '1.0'
id: news-20260816-633e90
title: Ipsen社が米Kartos社を買収へ、血液がん領域の後期開発パイプラインを拡充
url: https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/06/14860/
url_hash: 633e9049aea1358b6f9d1a63f2b058ac6b45c6a782e5bc9379ed859f1085bd23
canonical_url: https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/06/14860
source: bio.nikkeibp.co.jp
category: news/business
category_raw: business
region: null
tags:
- business
- pharmaceutical
- biotechnology
- merger_and_acquisition
lang: null
published_at: null
fetched_at: '2026-08-16T03:01:48.316080Z'
updated_at: '2026-08-20T20:11:18.491844Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- biotechnology
- business
- Business language visibility
- general news
- Ipsen
- Kartos
- merger_and_acquisition
- pharmaceutical
entities_en:
- name: Business language visibility
  type: method
topics_en:
- general news
numeric_facts: []
entities: []
key_facts: []
related: []
related_auto: []
computed_at: null
sanitized_at: '2026-08-20T14:56:50.092484+00:00'
---

# Ipsen社が米Kartos社を買収へ、血液がん領域の後期開発パイプラインを拡充

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- business / pharmaceutical / biotechnology / merger_and_acquisition

## Details
(本文なし。リンク先参照)

## Source
元記事: [Ipsen社が米Kartos社を買収へ、血液がん領域の後期開発パイプラインを拡充](https://bio.nikkeibp.co.jp/atcl/news/p1/26/08/06/14860/)